HIGHBuilt-in & outside partyProduct / Revenue mix
ASSURE WCD
“10-K Item 1A: 'We generate revenue primarily by leasing our ASSURE WCD to patients...will continue to account for nearly all of our revenue for the foreseeable future.'”
KMTS · Concentration risk · 10-K extracted
Kestra Medical Technologies, Lt (KMTS) concentration risks
Updated
The most significant concentration Kestra Medical Technologies, Lt discloses is ASSURE WCD, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Kestra Medical Technologies, Lt’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
At a glance
Disclosed-size breakdown · 1 disclosed concentration
HIGH1
MEDIUM0
LOW0
Disclosed concentrations
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
TrendMatrix Research · concentration synthesis
What these concentrations mean together
updated 2026-08-23Kestra Medical Technologies presents a concentration profile built around a single product line. The company generates revenue primarily by leasing its ASSURE wearable cardioverter defibrillator, and expects that product to continue accounting for nearly all of its revenue for the foreseeable future — a high-share exposure with a mixed character, since a single-product base represents both the entirety of Kestra's growth opportunity and its single largest point of failure. There is no disclosed customer, geographic, or supplier concentration alongside this — the entire disclosed risk here is product concentration itself. That means any disruption to ASSURE specifically, whether regulatory, competitive, reimbursement-related, or clinical, would flow directly through to total revenue rather than being cushioned by a diversified product portfolio. For a company at this stage, that concentration is often a function of being early-stage and single-product by design rather than a sign of business erosion, but it does mean investors should treat any ASSURE-specific news, positive or negative, as materially moving the entire investment thesis rather than one segment of it.
For the engine’s reasoning on KMTS’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
Industry peers · Medical Instruments & Supplies
Peer concentration profile
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| ATRC | AtriCure, Inc. | 1 | 1 | 1 | 3 |
| ATR | AptarGroup, Inc. | 1 | 1 | 0 | 2 |
| ALGN | Align Technology, Inc. | 1 | 0 | 0 | 1 |
| AVR | Anteris Technologies Global Cor | 1 | 0 | 0 | 1 |
| KMTS● | Kestra Medical Technologies, Lt | 1 | 0 | 0 | 1 |
| ANGO | AngioDynamics, Inc. | 0 | 0 | 0 | 0 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.